Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cardiovascular Research

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cvr/cvt036PMID 23417041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

  2013cited by this paper
• The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes

  2013cited by this paper
• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

  2013cited by this paper
• Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion

  2013cited by this paper
• Increase of arginase activity in old apolipoprotein-E deficient mice under Western diet associated with changes in neurovascular unit

  2012cited by this paper
• Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure

  2012cited by this paper
• Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway

  2012cited by this paper
• Diabetes-induced vascular dysfunction involves arginase I.

  2012cited by this paper
• Local Arginase Inhibition during Early Reperfusion Mediates Cardioprotection via Increased Nitric Oxide Production

  2012cited by this paper
• Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism.

  2012cited by this paper
• Nitric oxide synthases: regulation and function.

  2012cited by this paper
• The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term

  2012cited by this paper
• Impacts of Lisinopril and Lisinopril Plus Simvastatin on Erythrocyte and Plasma Arginase, Nitrite, and Nitrate in Hypertensive Patients

  2012cited by this paper
• Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus

  2012cited by this paper
• Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling.

  2011cited by this paper
• Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats.

  2011influential reference
• Association of serum arginase I with oxidative stress in a healthy population

  2011cited by this paper
• Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium.

  2011cited by this paper
• Endothelial dysfunction in hypertension: the role of arginase.

  2011cited by this paper
• Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes.

  2011cited by this paper
• Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.

  2011cited by this paper
• OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.

  2011influential reference
• Arginase I Attenuates Inflammatory Cytokine Secretion Induced by Lipopolysaccharide in Vascular Smooth Muscle Cells

  2011cited by this paper
• S-Nitrosation of arginase 1 requires direct interaction with inducible nitric oxide synthase

  2011cited by this paper
• Up-regulation of arginase II contributes to pulmonary vascular endothelial cell dysfunction during experimental pulmonary embolism.

  2011cited by this paper
• Oxidized Low‐Density Lipoprotein Inhibits Nitric Oxide‐Mediated Coronary Arteriolar Dilation by Up‐regulating Endothelial Arginase I

  2011cited by this paper
• Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension.

  2010cited by this paper
• Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease.

  2010cited by this paper
• Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.

  2010influential reference
• Macrophage Plasticity in Experimental Atherosclerosis

  2010cited by this paper
• Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia.

  2010cited by this paper
• Regulation of arginase pathway in response to wall shear stress.

  2010cited by this paper
• p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.

  2010cited by this paper
• Arginase Activities and Global Arginine Bioavailability in Wild-Type and ApoE-Deficient Mice: Responses to High Fat and High Cholesterol Diets

  2010cited by this paper
• Hypoxic upregulation of arginase II in human lung endothelial cells.

  2010cited by this paper
• Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.

  2010cited by this paper
• Impact of Arginase II on CBF in Experimental Cortical Impact Injury in Mice Using MRI

  2010cited by this paper
• Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling

  2010cited by this paper
• Arginase: an emerging key player in the mammalian immune system

  2009influential reference
• Misregulation of the arginase pathway in tissues of spontaneously hypertensive rats

  2009cited by this paper
• Melatonin Ameliorates Cerebral Vasospasm After Experimental Subarachnoidal Haemorrhage Correcting Imbalance of Nitric Oxide Levels in Rats

  2009cited by this paper
• Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase.

  2009cited by this paper
• Arginase activity mediates retinal inflammation in endotoxin-induced uveitis.

  2009cited by this paper
• Arginase II Knockout Mouse Displays a Hypertensive Phenotype Despite a Decreased Vasoconstrictory Profile

  2009cited by this paper
• Arginase Promotes Neointima Formation in Rat Injured Carotid Arteries

  2009cited by this paper
• Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

  2009cited by this paper
• Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model

  2009cited by this paper
• Involvement of the ornithine decarboxylase/polyamine system in precondition-induced cardioprotection through an interaction with PKC in rat hearts

  2009cited by this paper
• Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

  2008influential reference
• Arginase and vascular aging.

  2008influential reference
• Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis

  2008influential reference
• Treatment with the arginase inhibitor Nω-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat

  2008cited by this paper
• L-arginine plasma levels and severity of idiopathic pulmonary arterial hypertension.

  2008influential reference
• Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity.

  2008cited by this paper
• Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity

  2008influential reference
• Endothelial function and dysfunction: testing and clinical relevance.

  2007cited by this paper
• Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease.

  2007cited by this paper
• Role of polyamines in myocardial ischemia/reperfusion injury and their interactions with nitric oxide.

  2007influential reference
• MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge.

  2007cited by this paper
• Up‐regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans

  2007cited by this paper
• Inducible NO Synthase–Dependent S-Nitrosylation and Activation of Arginase1 Contribute to Age-Related Endothelial Dysfunction

  2007influential reference
• TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.

  2007cited by this paper
• ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION

  2007cited by this paper
• Time course of vascular arginase expression and activity in spontaneously hypertensive rats.

  2007cited by this paper
• TNF-&agr; Contributes to Endothelial Dysfunction by Upregulating Arginase in Ischemia/Reperfusion Injury

  2007cited by this paper
• Upregulation of Arginase by H2O2 Impairs Endothelium-Dependent Nitric Oxide–Mediated Dilation of Coronary Arterioles

  2006cited by this paper
• Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism.

  2006cited by this paper
• Oxidized Low-Density Lipoprotein–Dependent Endothelial Arginase II Activation Contributes to Impaired Nitric Oxide Signaling

  2006cited by this paper
• Endothelial NO Synthase Activity in Nucleus Tractus Solitarii Contributes to Hypertension in Spontaneously Hypertensive Rats

  2006cited by this paper
• Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium.

  2006cited by this paper
• Endothelial arginase: A new target in atherosclerosis

  2006cited by this paper
• Arginase: a modulator of myocardial function.

  2006cited by this paper
• Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism

  2006cited by this paper
• Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance.

  2006cited by this paper
• l‐Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin

  2006cited by this paper
• Gene Expression in Blood Changes Rapidly in Neutrophils and Monocytes after Ischemic Stroke in Humans: A Microarray Study

  2006cited by this paper
• Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats

  2006cited by this paper
• Arginine metabolism in vascular biology and disease

  2005cited by this paper
• Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension.

  2005cited by this paper
• Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

  2005cited by this paper
• Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity.

  2005cited by this paper
• Arginine metabolism in vascular biology and disease

  2005cited by this paper
• Arginine/arginase NO NO NO.

  2005cited by this paper
• Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.

  2005cited by this paper
• Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension

  2004influential reference
• Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.

  2004cited by this paper
• Neuroprotective effects of spermine following hypoxia‐ischemia‐induced brain damage: A mechanistic study

  2004cited by this paper
• Upregulation of Vascular Arginase in Hypertension Decreases Nitric Oxide–Mediated Dilation of Coronary Arterioles

  2004cited by this paper
• Thrombin Stimulates Human Endothelial Arginase Enzymatic Activity via RhoA/ROCK Pathway: Implications for Atherosclerotic Endothelial Dysfunction

  2004influential reference
• Ischemia‐reperfusion selectively impairs nitric oxide‐ mediated dilation in coronary arterioles: counteracting role of arginase

  2003cited by this paper
• Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I

  2003cited by this paper
• Endothelial Dysfunction: A Marker of Atherosclerotic Risk

  2003cited by this paper
• Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels

  2003cited by this paper
• Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases.

  2002cited by this paper
• Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation

  2001cited by this paper
• Direct vascular effects of HMG-CoA reductase inhibitors.

  2000cited by this paper
• The Involvement of Tyrosine Kinases, Cyclic AMP/Protein Kinase A, and p38 Mitogen-Activated Protein Kinase in IL-13-Mediated Arginase I Induction in Macrophages: Its Implications in IL-13-Inhibited Nitric Oxide Production1

  2000cited by this paper
• Arginase: a binuclear manganese metalloenzyme.

  2000cited by this paper
• INCREASED ARGINASE ACTIVITY IN AORTA OF MINERALOCORTICOID-SALT HYPERTENSIVE RATS

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper

• VEGF Mimetic Peptide-Modified Bifunctional Nanosystem for Targeted Drug Delivery in Myocardial Infarction.

  2026cites this paper
• Pathological mechanisms and clinical research progress of endothelial dysfunction.

  2026cites this paper
• A novel bead-based assay for selective measurement of arginase 1 activity in human serum.

  2026cites this paper
• Metagenome-assembled genomes reveal microbial signatures and metabolic pathways linked to coronary artery disease

  2025cites this paper
• Cinnamon consumption during aerobic training in streptozotocin–nicotinamide-induced type 2 diabetic rats modulates the arginase/eNOS enzyme balance in the soleus muscle and reduces blood glucose levels

  2025cites this paper
• The Impact of Glycaemic Variability on Vascular Dysfunction in Diabetes

  2025cites this paper
• L‐arginine ameliorates hypertension and cardiac mitochondrial abnormalities but not cardiac injury in male metabolic syndrome rats

  2025cites this paper
• NO-cGMP Signaling in Endothelial Function of the Healthy and Inflamed Dental Pulp

  2025cites this paper
• The Physiological Roles and Pathological Implications of Urea Transporters in the Cardiovascular System

  2025cites this paper
• Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction

  2025cites this paper
• Pharmacological targeting of endothelial nitric oxide synthase dysfunction and nitric oxide replacement therapy.

  2025cites this paper
• Comparison of PDE-5 inhibitors used in erectile dysfunction with some candidate molecules: A study involving molecular docking, ADMET, DFT, biological target, and activity

  2025cites this paper
• Eosinophils in Rheumatoid Arthritis: A Multifaceted Role in the Pathogenesis of the Disease

  2025cites this paper
• l-Arginine: A multifaceted regulator of diabetic cardiomyopathy.

  2025cites this paper
• Oxidative Stress-related Gene Signature: A Prognostic Tool for Predicting Survival in ST-elevation MI

  2025cites this paper
• Promotion of nitric oxide production: mechanisms, strategies, and possibilities

  2025cites this paper
• Citrulline and ADI-PEG20 reduce inflammation in a juvenile porcine model of acute endotoxemia

  2024cites this paper
• Physiological and Pathophysiological Relevance of Nitric Oxide Synthases (NOS) in Retinal Blood Vessels.

  2024cites this paper
• Tuberculous pleural effusion-induced Arg-1+ macrophage polarization contributes to lung cancer progression via autophagy signaling

  2024cites this paper
• Ameliorative influence of co-administration of p-coumaric acid and lisinopril on blood pressure and crucial enzymes relevant to hypertension in L-arginine N-ω-nitro-L-arginine methyl ester (L-NAME)-induced hypertension in rats

  2024cites this paper
• Sodium valproate treatment reverses endothelial dysfunction in aorta from rabbits with acute myocardial infarction.

  2024cites this paper
• Sex-specific differences in the mechanisms for enhanced thromboxane A2-mediated vasoconstriction in adult offspring exposed to prenatal hypoxia

  2024cites this paper
• Novel Targets and Potential Mechanisms of Mizuhopecten yessoensis-Derived Tripeptide NCW as Antihypertensive Peptides.

  2024cites this paper
• Investigate Performance of ATGF nanocomposite based on guar gum polymer for adsorption of Congo Red dye and alpha lipoic acid drug from wastewater: study kinetics and simulation

  2024cites this paper
• Red blood cell-derived arginase release in hemolytic uremic syndrome

  2024cites this paper
• Cardiac Urea Cycle Activation by Time‐Restricted Feeding Protects Against Pressure Overload‐Induced Heart Failure

  2024cites this paper
• Exploring synergistic effects of Achyranthes bidentata Blume and Paeonia lactiflora Pall. on hypertension with liver yang hyperactivity using the multidisciplinary integrative strategy

  2024cites this paper
• The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology.

  2024cites this paper
• Opportunities and Challenges of Arginase Inhibitors in Cancer: A Medicinal Chemistry Perspective.

  2024cites this paper
• Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances

  2024cites this paper
• Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets

  2023cites this paper
• Endothelial Dysfunction and Its Relation in Different Disorders: Recent Update

  2023cites this paper
• Arginine Dysregulation and Myocardial Dysfunction in a Mouse Model and Children with Chronic Kidney Disease

  2023cites this paper
• Progress in molecular mechanisms of coronary microvascular dysfunction

  2023cites this paper
• Chronic anemia is associated with systemic endothelial dysfunction

  2023cites this paper
• Arginase inhibitory activities of guaiane sesquiterpenoids from Curcuma comosa rhizomes

  2023cites this paper
• Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review

  2023cites this paper
• Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma

  2023cites this paper
• Hibiscus sabdariffa fractions attenuate oxidative stress and some cardiac biomarkers in sodium fluoride(NaF)-induced cardiotoxicity rat

  2023cites this paper
• Development of a novel Ultra Performance Liquid Chromatography Tandem-Mass Spectrometry (UPLC-MS/MS) method to measure L-arginine metabolites in plasma.

  2023cites this paper
• Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction

  2023cites this paper
• Combined Citrulline and Glutathione Supplementation Improves Endothelial Function and Blood Pressure Reactivity in Postmenopausal Women

  2023cites this paper
• Regulatory effects of curcumin on nitric oxide signaling in the cardiovascular system.

  2023cites this paper
• A Low Arginine/Ornithine Ratio is Associated with Long-Term Cardiovascular Mortality

  2023cites this paper
• Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

  2023cites this paper
• The Potential of Single Nucleotide Polymorphisms (SNPs) as Biomarkers and Their Association with the Increased Risk of Coronary Heart Disease: A Systematic Review

  2023cites this paper
• Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases

  2022influential citation
• Pathophysiological correlation of arginase-1 in development of type 2 diabetes from obesity in adolescents.

  2022cites this paper
• Effect of 8 Weeks of Aerobic Exercise With Cinnamon Extract Supplementation on Arginase and P 38 MAPK Levels of Soleus Muscle in Diabetic Rats

  2022cites this paper
• Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications

  2022cites this paper
• Morin Augmented Myocardial eNOS/cGMP/PKG Signaling Pathway and Abated Oxidative and Inflammo-apoptotic Responses in Diethyl Phthalate and Bisphenol-S Co-Exposed Male Albino Rats

  2022cites this paper
• Evaluate the activity of arginase and some biochemical parameters in patients with atherosclerosis

  2022cites this paper
• Cell-To-Cell Communication in the Resistance Vasculature.

  2022cites this paper
• Dietary Nitrate Supplementation and Small Muscle Mass Exercise Hemodynamics in Patients with Essential Hypertension.

  2022cites this paper
• Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

  2022cites this paper
• Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease

  2022cites this paper
• Effects of arginase inhibition on myocardial Ca2+ and contractile responses

  2022cites this paper
• Antihyperglycemic activity of L-norvaline and L-arginine in high-fat diet and streptozotocin-treated male rats.

  2022cites this paper
• Identifying medically relevant xenon protein targets by in silico screening of the structural proteome

  2022cites this paper
• Butanol Fraction of Rivea ornata Attenuate Endothelial Dysfunction in Rats via Modulation of Cardiovascular Risk Factors

  2022cites this paper
• Influence of lemon (Citrus limon) and lime (Citrus aurantifolia) juices on the erectogenic properties of sildenafil in rats with L-NAME-induced erectile dysfunction.

  2022cites this paper
• Vanillic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension by Enhancing NO Signaling Pathways

  2022cites this paper
• Role of Erythrocytes in Nitric Oxide Metabolism and Paracrine Regulation of Endothelial Function

  2022cites this paper
• Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy

  2022cites this paper
• Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial

  2022cites this paper
• Association of Red Blood Cell Life Span with Abnormal Changes in Cardiac Structure and Function in Non-Dialysis Patients with Chronic Kidney Disease Stages 3–5

  2022cites this paper
• Congenital diaphragmatic hernia: phosphodiesterase-5 and Arginase inhibitors prevent pulmonary vascular hypoplasia in rat lungs.

  2022cites this paper
• Comprehensive Metabolic Profiling of Inflammation Indicated Key Roles of Glycerophospholipid and Arginine Metabolism in Coronary Artery Disease

  2022influential citation
• Mammalian Arginase Inhibitory Activity of Methanolic Extracts and Isolated Compounds from Cyperus Species

  2021cites this paper
• Novel perspectives on redox signaling in red blood cells and platelets in cardiovascular disease.

  2021cites this paper
• Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease

  2021cites this paper
• Alzheimer’s disease as a chronic maladaptive polyamine stress response

  2021cites this paper
• Arginine Metabolites as Biomarkers of Myocardial Ischaemia, Assessed with Cardiac Magnetic Resonance Imaging in Chronic Kidney Disease

  2021cites this paper
• Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability

  2021cites this paper
• Red blood cells from patients with pre-eclampsia induce endothelial dysfunction

  2021cites this paper
• Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia.

  2021cites this paper
• Protection against Doxorubicin-Induced Cardiotoxicity through Modulating iNOS/ARG 2 Balance by Electroacupuncture at PC6

  2021cites this paper
• Long lasting protective effects of early l-arginine treatment on endothelium in an in vitro study.

  2021cites this paper
• Therapeutic enzymes as non-conventional targets in cardiovascular impairments:A Comprehensive Review.

  2021cites this paper
• Nitric oxide role in pathogenesis and treatment of cardio-vascular diseases (literature review)

  2021cites this paper
• Arginase 2 and Polyamines in Human Pancreatic Beta Cells: Possible Role in the Pathogenesis of Type 2 Diabetes

  2021cites this paper
• Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway

  2021cites this paper
• Reactive Oxygen Species and Antioxidative Defense in Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Review of arginase as a promising biocatalyst: characteristics, preparation, applications and future challenges

  2021cites this paper
• Role of Harmaline in liver cirrhosis protection via arginase-I activity modulation in liver

  2021cites this paper
• Arginase Signalling as a Key Player in Chronic Wound Pathophysiology and Healing

  2021cites this paper
• Arginase 1 is upregulated at admission in patients with ST‐elevation myocardial infarction

  2021cites this paper
• Regulation of NOS expression in vascular diseases.

  2021cites this paper
• Nitric oxide signalling in kidney regulation and cardiometabolic health

  2021cites this paper
• L-Citrulline: A Non-Essential Amino Acid with Important Roles in Human Health

  2021cites this paper
• Endothelial Dysfunction Driven by Hypoxia—The Influence of Oxygen Deficiency on NO Bioavailability

  2021cites this paper
• The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction

  2021cites this paper
• Possible contribution of hepatocyte secretion to the elevation of plasma exosomal arginase-1 in high-fat diet-fed mice.

  2021cites this paper
• Fetal oxygen supply can be improved by an effective cross-talk between fetal erythrocytes and vascular endothelium.

  2021cites this paper
• Alzheimer ’ s disease as a chronic maladaptive polyamine stress response Review

  2021cites this paper
• Study the Sensitivity and Specificity of Urinary Arginase in Bladder Cancer Patients in Babylon Governorate

  2020cites this paper
• Polyphenolic compounds of Euphorbia umbellata (Pax) Bruyns (Euphorbiaceae) improved endothelial dysfunction through arginase inhibition

  2020cites this paper
• Human-based evidence for the therapeutic potential of arginase inhibitors in cardiovascular diseases.

  2020cites this paper
• Obesity-Related Endothelial Dysfunction: moving from classical to emerging mechanisms

  2020cites this paper
• Poor glycemic control impairs the cardioprotective effects of red blood cells on myocardial ischemia/reperfusion injury.

  2020cites this paper